Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Income from Continuing Operations (2016 - 2018)

Historic Income from Continuing Operations for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$1.1 million.

  • Armata Pharmaceuticals' Income from Continuing Operations rose 5318.88% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$9.4 million, marking a year-over-year increase of 2749.38%. This contributed to the annual value of -$53.2 million for FY2024, which is 2270.81% down from last year.
  • Armata Pharmaceuticals' Income from Continuing Operations amounted to -$1.1 million in Q4 2018, which was up 5318.88% from -$2.8 million recorded in Q3 2018.
  • Armata Pharmaceuticals' Income from Continuing Operations' 5-year high stood at -$779000.0 during Q3 2017, with a 5-year trough of -$11.3 million in Q1 2014.
  • Moreover, its 5-year median value for Income from Continuing Operations was -$2.9 million (2015), whereas its average is -$3.9 million.
  • In the last 5 years, Armata Pharmaceuticals' Income from Continuing Operations tumbled by 69125.26% in 2014 and then skyrocketed by 7661.1% in 2017.
  • Over the past 5 years, Armata Pharmaceuticals' Income from Continuing Operations (Quarter) stood at -$2.6 million in 2014, then dropped by 10.4% to -$2.9 million in 2015, then tumbled by 250.75% to -$10.1 million in 2016, then skyrocketed by 76.61% to -$2.4 million in 2017, then skyrocketed by 53.19% to -$1.1 million in 2018.
  • Its last three reported values are -$1.1 million in Q4 2018, -$2.8 million for Q3 2018, and -$3.2 million during Q2 2018.